The global osteoporosis drugs market is expected to grow at a CAGR of ~4.7% during the period 2016 to 2022.
Osteoporosis is a disease characterized by reduced bone mass and damage to its micro-architecture resulting in greater risk of fractures. Women comprise almost 80% of those affected and the disease has a propensity towards Caucasians and Asians as compared to African people. The market for osteoporosis drugs is rising with a CAGR of 4.7% and is expected to reach $14,300 million in 2022.
The market driving factors are rise in the geriatric population, increased screening, drug induced osteoporosis, alcoholism and smoking, increased awareness and focus towards female health, rising prevalence of diseases, conditions and medical procedures that may cause bone loss such as cancer, autoimmune disorders, thalassemia, hormonal disorders, modern lifestyle etc.
The market constraining factors are loss of patents of block busters, greater penetration of generics and fragmentation of market, poor efficacy and side effects of present therapies, non-life threatening nature and poor symptoms of osteoporosis etc.
The market is characterized by difficult penetration due to a large number of players and growing fragmentation due to rise in generics. Thus what was a unified market a few years ago is now getting fragmented.
Bio phosphates as a drug class dominates the market with a share of greater than 40% while hormonal therapy is losing ground due to its side effects.
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2479
Major Key Players
- Eli Lilly and Company,
- Merck & Co., Inc.,
- Novartis International AG,
- Amgen Inc.,
- F. Hoffmann La Roche Ltd.,
- Pfizer Inc.,
- Novo Nordisk A/S,
- Teva Pharmaceutical Industries Ltd.
Global Osteoporosis Drugs Market:
The global osteoporosis drugs market has been evaluated as a growing market and it is expected that the market will touch moderate growth figures in future. The global osteoporosis drugs market is expected to grow with CAGR of 4.7% during the forecast period. However major players have started losing the market share to smaller players due to loss of patents and the lack of equal efficacious drugs as compared to bio phosphates. The market is hungry for a novel drug with a different action as compared to bio phosphates, which will be rapidly absorbed by market with minimum marketing costs in face of side effects of the current drug regimens.
Test the market data and market information presented through more than 60 market data tables and figures spread over 84 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Osteoporosis Drugs Market Research Report – Forecast to 2022”.
Depending on geographic region, osteoporosis drugs market is segmented into four key regions: America, Europe, Asia Pacific, and Middle East & Africa. Globally, America is the largest market for osteoporosis drugs followed by Europe and will continue to hold its market share in the near future. Asia pacific region is expected to be fastest growing region in osteoporosis drugs market due to increasing investments in the healthcare sector and increasing awareness towards the disease especially women health.
Global osteoporosis drugs market has been segmented on the basis of drug class which comprises Bisphosphonates, Calcitonin’s, selective estrogen receptor modulators (SERMS), parathyroid hormone (PTH) and others. On the basis of route of administration; market is segmented into oral, injectable and others. On the basis of gender the market is segmented into male and female.
Access Report Details @ https://www.marketresearchfuture.com/reports/osteoporosis-drugs-market
Table of Content
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
List of Tables
TABLE 1 GLOBAL OSTEOPOROSIS DRUGS MARKET, 2013-2022 (USD MILLION)
TABLE 2 GLOBAL OSTEOPOROSIS DRUGS MARKET, BY DRUG CLASS, 2013-2022 (USD MILLION)
TABLE 3 GLOBAL OSTEOPOROSIS DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2013-2022 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 GLOBAL OSTEOPOROSIS DRUGS MARKET, BY DRUG CLASS
FIGURE 4 GLOBAL OSTEOPOROSIS DRUGS MARKET, BY ROUTE OF ADMINISTRATION
Browse Related Statistical Report
Americas Dental Consumables Market, is projected to grow at a CAGR of 5.7% and is expected to reach US$ 8,328.7 million by 2024. In Americas Dental Consumables Market, North America accounted for the largest market share in 2015.
Globally, Americas Dental Consumables is one of the fastest growing industry. The Americas market comprises of three main regions; North America, Central America and South America. North America market includes countries like US and Canada. In Central America, Mexico and Cost Rica comprise of majors dental consumables market. Columbia, Argentina, Chile and Ecuador are major markets in South America.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India